5 Results for "

nociceptor receptor

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "nociceptor receptor" in MCE Product Catalog:

Cat. No.: HY-168758
CAS No.: 567-72-6
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Delta3,5-cholestadien-7-one is an oxysterol and a negative allosteric modulator of GABAA receptors. Delta3,5-cholestadien-7-one reduces GABA-induced currents in HEK cells expressing α1β1γ2 or α4β3γ2 subunit-containing GABAA receptors with IC50 values of 1.5 and 1 µM, respectively. Delta3,5-cholestadien-7-one reduces GABA-induced depolarization of peptidergic and non-peptidergic nociceptors, C-LTMRs, and cold thermosensors in isolated mouse dorsal root ganglion (DRG) neurons .
loading...
    loading...
Cat. No.: HY-120385
CAS No.: 1357348-09-4
Synonyms: GRT-6006
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Lexanopadol (GRT-6006) is a μ-opioid receptor and nociceptor receptor (ORL-1 receptor) agonist. Lexanopadol can be used to study pain .
loading...
    loading...
Cat. No.: HY-108576
CAS No.: 113168-57-3
Synonyms: DuP 996 dihydrochloride
Target:  

TRP Channel

Research Areas:  

Neurological Disease

Linopirdine dihydrochloride is a agonist of capsaicin receptor TRPV1. Linopirdine increases the intracellular calcium concentration in HEK293 cells. Linopirdine dihydrochloride exerts an excitatory action on mammalian nociceptors .
loading...
    loading...
Cat. No.: HY-161273
Target:  

TRP Channel

Research Areas:  

Neurological Disease

TRPV1 antagonist 6 (compound 51) is a mode-selective antagonist for transient receptor potential vanilloid member 1 (TRPV1), which shows antagonism with IC50 of 2.85 nM to capsaicin activation and 28.48 % inhibition against proton activation at a 3 µM concentration .
loading...
    loading...
Cat. No.: HY-P2027
CAS No.: 103412-40-4
Target:  

Bradykinin Receptor

B 4310 is a non-organ-selective Bradykinin antagonist. B 4310 induces uterine contraction in rats. B 4310 blocks bradykinin-mediated responses, including substance P release, plasma extravasation, venous contraction, prostaglandin E2 release and trigeminal nerve stimulation, but exerts no effect on angiotensin II, acetylcholine or capsaicin pathways. B 4310 exerts a reversible antagonistic effect on bradykinin-induced nociceptors. B 4310 serves as a tool for investigating the biological effects of bradykinin .
loading...
    loading...